Early neo2 Registry Core-Lab Results (TVT, 2021)

August 25, 2021

See the ACURATE neo2TM Aortic Valve System’s 1st real-world, core-lab adjudicated clinical data as presented by Dr. Andreas Rück from the Karolinska Institute (Stockholm, Sweden). The Early neo2 Registry was an investigator-initiated and conducted, single arm, multicenter registry that assessed the ACURATE neo2 Valve’s performance during TAVI. Echocardiographic images of 85% of the Early neo2 Registry patients were analyzed in a core-lab analysis – watch this replay from TVT, 2021 to see those results.
Login to view comments. Click here to Login